ROTATION DESCRIPTION

Similar documents
ROTATION DESCRIPTION - PGY1 Adult Internal Medicine

Stellar Hospital PGY-1 Pharmacy Residency

Acute Care Cardiology Learning Description at Emory University Hospital Midtown (EUHM)

Neurology Clinic - Ambulatory Care I & II

Medical Intensive Care Unit Rotation EUHM

ROTATION DESCRIPTION FORM PGY1

Antimicrobial EUHM Learning Activities:

Infectious EUH Learning Activities:

Neurocritical Care Rotation - EUH

ROTATION DESCRIPTION

PGY-2 PEDIATRIC PHARMACY RESIDENCY MEDICAL UNIVERSITY OF SOUTH CAROLINA

Liver EUH Learning Activities:

PGY 1 Pharmacy Residency Cardiology Experience Description Truman Medical Center Hospital Hill

PGY2 AMBULATORY CARE PHARMACY RESIDENCY MEDICAL UNIVERSITY OF SOUTH CAROLINA

Liver Transplant EUH Learning Activities:

University of Utah PGY-1 Pharmacy Practice Primary Care: Ambulatory I & II Rotation Salt Lake City, Utah

University of Virginia Health System Department of Pharmacy Services PGY2 Drug Information Residency Residency Purpose Statement

PGY1 Course Description

Postgraduate Year One (PGY1) Pharmacy Residency Program

Florida A&M University College of Pharmacy & Pharmaceutical Sciences

Department of Pharmacy Services PGY1 Residency Program. Residency Manual

PGY1: Pediatric Cardiovascular Intensive Care Unit Riley Hospital for Children at Indiana University Health

Educational Outcomes, Goals, and Objectives for Postgraduate Year Two (PGY2) Pharmacy Residencies in Emergency Medicine

Block Title: Patient Care Experience Block #: PHRM 701, 702, 703, 704 and PHRM 705, 706, and 707 (if patient care)

Educational Outcomes, Goals, and Objectives for Postgraduate Year Two (PGY2) Pharmacy Residencies in Internal Medicine

Pharmacy Leadership and Administration Learning Experience Rev 12/16/16

Neonatal Intensive Care Unit EUHM

Prepared Jointly by the American Society of Health-System Pharmacists and the Academy of Managed Care Pharmacy

University Campus PGY1 Pharmacy Residency. The University of Arizona Medical Center University Campus

Disclosures. Objectives. Leveraging and Developing Your Team for Optimal Outcomes. None

PGY1 Medication Safety Core Rotation

Managed Care Pharmacy Practice Residency

Drug EUHM Learning Activities:

Learning Experiences Descriptions

UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016

PRE-SURVEY QUESTIONNAIRE AND SELF-ASSESSMENT CHECKLIST FOR THE ACCREDITATION OF A POSTGRADUATE YEAR ONE (PGY1) PHARMACY RESIDENCY PROGRAM

UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM

Competency Areas: Categories of the residency graduates capabilities.

Course Descriptions for PharmD Classes of 2021 and Beyond updated November 2017

Disease State Management Clinics: A Pharmacist Perspective

Transition of Care Practices. Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit, MI

UNMC COLLEGE OF PHARMACY ADVANCED PHARMACY PRACTICE EXPERIENCE (APPE) SYLLABUS (Revised February 2013, Approved April 2013)

Park Nicollet Medication Management

1) Goal Fellows will become competent in caring for renal transplant patients and patients with renal complications of non-renal transplants.

ASHP Accredited PGY1 & PGY2 Residency with Master s Degree in Health-System Pharmacy Administration

PAIN MANAGEMENT AND PALLIATIVE CARE TRAINEESHIP, LEVEL 3

UNMC COLLEGE OF PHARMACY ADVANCED PHARMACY PRACTICE EXPERIENCE SYLLABUS (Revised November 2014)

Antithrombotic Traineeship

Competency Areas: Categories of the residency graduates capabilities.

Ambulatory Care Advanced Pharmacy Practice Experience SPPS 401A SPPS 401B

ELECTIVE COMPETENCY AREAS, GOALS, AND OBJECTIVES FOR POSTGRADUATE YEAR ONE (PGY1) PHARMACY RESIDENCIES

UNMC COLLEGE OF PHARMACY ADVANCED PHARMACY PRACTICE EXPERIENCE (APPE) SYLLABUS (November 2014) (Approved December 2014)

APPE Acute Care Rotation Evaluation of Student

PHARMACY (PHAR) PHAR 534. Foundations III. 1.5 Hour.

Community Pharmacy Advanced Pharmacy Practice Experience SPPS 402

School of Pharmacy. Dual Degree. Courses Pharmacy Practice Courses. Programs Doctor of Philosophy (PhD) Doctor of Pharmacy (PharmD)

Home Infusion (elective)

Curricular area: Specific Rotations: Responsible faculty: Goals: Setting: Key to Competencies Teaching activities: Level of supervision:

Experiential Education

PHCY 471 Community IPPE. Student Name. Supervising Preceptor Name(s)

Required Educational Outcomes, Goals, and Objectives for Postgraduate Year Two (PGY2) Pharmacy Residencies in Solid Organ Transplant

Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess.

CHOC Children s Department of Pharmacy Services Post Graduate Year Two Residency Program Residency Handbook

Ambulatory Care Advanced Pharmacy Practice Experience Course Title: PHAR 9981

PGY1: Pediatric Infectious Diseases Riley Hospital for Children Indiana University Health

P1 Fall SCCP 602/COP 601: Foundations of Pathophysiology and Pharmacology I This is the first course in a 2-semester sequence providing important

PGY1 Infectious Disease Longitudinal Rotation

Informatics and Technology (elective)

COMBINED INTERNAL MEDICINE & PEDIATRICS Department of Medicine, Department of Pediatrics SCOPE OF PRACTICE PGY-1 PGY-4

Clinical Nurse Leader (CNL ) Certification Exam. Subdomain Weights for the CNL Certification Examination Blueprint (effective February 2012)

PGY1 Oncology 2 Advanced Learning Experience

REQUIRED COMPETENCY AREAS, GOALS, AND OBJECTIVES FOR POSTGRADUATE YEAR ONE (PGY1) COMMUNITY BASED PHARMACY RESIDENCIES

Mission: To extend the presence and healing ministry of Christ in all we do.

American Journal of Pharmaceutical Education 2003; 67 (3) Article 88.

PGY1 - Project Learning Experience Description

REQUIRED COMPETENCY AREAS, GOALS, AND OBJECTIVES FOR POSTGRADUATE YEAR TWO (PGY2) CARDIOLOGY PHARMACY RESIDENCIES

Policies and Procedures for In-Training Evaluation of Resident

Achievement of ACGME Core Competencies by Level of Training: PGY-3

OVERALL GOALS AND OBJECTIVES FOR EACH RESIDENT LEVEL 3 rd YEAR GENERAL SURGERY RESIDENT PATIENT CARE

PHARMACY PRACTICE. Residency Program

Nursing (NURS) Courses. Nursing (NURS) 1

Domain: Clinical Skills and Knowledge A B C D E Self Assessment NURSING PROCESS Assessment. Independently and consistently

CAPE/COP Educational Outcomes (approved 2016)

Acute Care Advanced Pharmacy Practice Experience SPPS 400A SPPS 400B

College of Pharmacy. Pharmacy Practice and Science

ROTATION DESCRIPTION FORM PGY2 CRITICAL CARE

College of Pharmacy Pharm.D Program. Alfaisal University

Administration ~ Education and Training (919)

Developing a Syllabus

PGY1 Oncology Rotation

PRE-SURVEY QUESTIONNAIRE AND SELF-ASSESSMENT CHECKLIST FOR ACCREDITATION OF: POSTGRADUATE YEAR ONE (PGY1) COMMUNITY PHARMACY RESIDENCY PROGRAMS

Hospital / Health-System Advanced Pharmacy Practice Experience SPPS 403

CONTINUING PHARMACY EDUCATION (CPE) Project Planning Form for Live and Enduring Activities

PGY-1 Pediatric Pharmacy Residency Program PhORCAS Program Code

Supply Chain Management

Investigational Drug Service (IDS) Rotation Tool APPE Student Rotation

Ambulatory Care Clinical Management

Transition of Care Practices. Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit

OVERALL GOALS & OBJECTIVES FOR EACH RESIDENT LEVEL FIRST-YEAR RESIDENT. Patient Care

PGY1 Pharmacy Residency Program Overview

Transcription:

ROTATION DESCRIPTION ROTATION TITLE: PGY1 - Outpatient Transplant Ambulatory Care PURPOSE The Medical Center performed over 200 abdominal organ transplants annually. This clinical practice site will provide the PGY1 pharmacy resident with the opportunity to develop the patient-care management skills necessary to care for the complex medical issues associated with adult and pediatric transplant recipients. Outpatient transplant pharmacists provide medication education, disease-state management recommendations, and intervene to optimize the monitoring and medication adjustments necessary to provide long-term care in this patient population. LEARNING EXPERIENCE DESCRIPTION Upon successful completion of this rotation, the PGY1 resident should be able to: begin to understand the role of the transplant pharmacist on a multidisciplinary team; develop skills necessary to communicate effectively with patients and other members of the multidisciplinary transplant team; manage and monitor the care of outpatient transplant recipients through programmatic specific protocols; design patient care plans that provide optimal pharmacotherapy while accounting for disease-specific factors; ensure continuity of care from the outpatient ambulatory clinic to inpatient admission; evaluate transplant and ambulatory care literature and begin to provide evidenced-based pharmacotherapy recommendations; document pharmaceutical care activities using pharmacotherapy notes; describe the etiology and pathophysiology of common diseases that lead to end-stage kidney and liver disease necessitating transplantation; explain pharmacotherapy requirements for solid organ transplant recipients and provide an outline of common drug-drug and disease-drug interactions; describe the pathophysiology and management for common comorbid conditions found in transplant patients; lead transplant specific pharmacotherapy discussions; provide patient and caregiver education. LEARNING EXPERIENCE ACTIVITIES The following activities are required during transplant clinic rotation for a PGY1 resident. Activities directly related to RLS objectives evaluated on this rotation are noted. 1. Collect and interpret all relevant data needed to optimize medications and identify medication related issues in a transplant patient a. Collect and analyze patient information (R2.4) b. Determine the presence of medication therapy problem's in the patients current medication regimen (R2.4.2) c. Using an organized collection of patient specific information, summarize patient's health care needs (R2.4.3) 2. Based on patient specific factors, set short and long-term pharmacotherapeutic goals for each patient encountered a. Design evidence-based therapeutic regimens - Specify therapeutic goals for a patient incorperating the principles of evidenced based medicine that integrate patient specific data disease and medication specific information, ethics, and quality of life considerations (R2.6.1, R2.7.1)

b. Design a patient centered regimen that meets the evidence based therapeutic goals established for a patient; integrates patient specific information, ethical issues and quality of life issues, and considers pharmacoeconomic prinicples (R2.6.2) c. Exercise skills in systematic resolution of problems arising in the operation of the service (R3.2.10) d. Specify therapeutic goals for an internal medicine patient incorperating the principles of evidenced based medicine specific informaiton, ethics, and quality of life considerations (R2.6.1) e. Display initiative in preventing, identifying, resolving pharmacy related patient care problems (R4.3.2) f. Display initiative in preventing, identifying and resolving pharmacyrelated patient care problems (R1.4) 3. Develop and implement a pharmacotherapy plan designed to achieve desired goals for optimize short and long-term patient outcomes a. Demonstrate a commitment to advocacy for the optimal care of patients through the assertive and persuasive presentation of patient care issues to members of the health care team, the patient or the patient's caregivers (R3.1.3) b. Create an efficient and effective advanced search strategy to prepare a drug information response (R1.5.1) c. When presented with limited evidence-based biomedical literature, synthesize a reasonable response for a specific drug information need (R1.5.9) d. When presented with an internal medicine patient with health care needs that cannot be met by the internal medicine pharmacy specialist, make a referral or consult with the appropriate health care provider based on the paiten's acuity and the presenting problem (R2.5.1) e. Design a regimen that meets the evidence based therapeutic goals established for the internal medicine patient - integrates patient specific information, ethical issues and quality of life issues, and considers pharmacoeconomic principles (R2.6.2, R2.7.1, R2.6, R2.6) f. Implement regimens and monitoring plans (R2.9) g. Recommend or communicate a patient-centered, evidenced based therapeutic regimen and corresponding monitoring plan to other members of the interdisciplinary team and patients in a way that is sytematic, logical, accurate, timely and secures consensus from the team and patient (R2.8.1) h. When appropriate, initiate patient centered, evidence based therapeutic regimen and monitoring plan for a patient according to the organization's policies and procedures (R2.9.1) i. Evaluate patient's progress and redesign regimens and monitoring plans (R2.10, R2.10.1, R2.11.1) 4. Document all appropriate activities in the patient medical record a. Appropriately select direct patient care activities for documentation (R2.12.1) 5. Provide education to patients, caregivers, and providers to ensure optimal medication utilization. Use effective communication skills with all these activities

a. Use effective patient education techniques to provide counseling to patients and caregivers, including information on medication therapy, adverse effects, compliance, appropriate use, handing and medication administration (R2.9.2) b. Use effective negotiation skills to resolve conflicts (R3.1.4) c. Explain the nature of mentoring in pharmacy. Its potential connection with achievement, and the importance and willingness to serve as a mentor to appropriate individuals (R3.1.5) d. Use effective communication skills to report orally the study results and recommendations (R3.3.8) e. Establish a collaborative patient centered pharmacist patient and pharmacist caregiver relationship (R2.3.1, R2.3) f. When necessary, contribute to the work of the team that secures access to drugs used in the patient's regimen (R2.9.3) g. Use effective educational techniques to provide counseling to internal medicine patients and caregivers, including information on medication therapy, adverse effects, compliance, appropriate use, handling, storage, and medication administration (R2.9.4) h. Implement a strategy that effectively establishes cooperative, collaborative, and communicative working relationships with members of interdisciplinary health care team (R2.1, R2.1.1) i. Use effective communication practices when documenting a direct patient care activity (R2.12.2) 6. Lead and actively participate in transplant-related topic discussions, which incorporate primary literature and allow the resident to build a repository of journal articles and contribute to the goal of providing evidence based pharmacotherapy recommendations a. Employ advanced literature analysis skills in preparing drug information (R1.5) 7. Act ethically and display professional behavior and attitude. a. Practice self-managed continuing professional development with the goal of improving the quality of one's own performance through selfassessment and personal change (R3.1.1, R4.3) b. Assure that the service operates in accord with legal and regulatory requirements (R3.2.2) REQUIREMENTS OF LEARNING EXPERIENCE Required Hours Generally the resident will need to be present from 8 am to 5 pm. These hours may vary based on the resident s efficiency, activities occurring that day, and non-rotation activities. The resident shall alert the preceptor if they anticipate they will exceed the resident work hours set forth in the ACGME policy on resident work hours. Required Meetings Daily clinic Ambulatory Care Pharmacotherapy Discussion Series, times and days vary month to month, usually involve 5 to 6 topics per month, usually twice weekly discussions in the afternoons

Bar and Grill Patient Case-Based Discussions varies, usually each Friday afternoon, for 3 or 4 sessions per month Transplant Journal Club: varies, usually 3 rd Wednesday of Month 4 to 5 PM Pharmacy Critical Care Journal Club: varies, usually 2 nd Tuesday of Month 1 to 2 PM Pharmacy Resident Seminar: Mondays, 1:00-2:00pm Pharmacy Resident RITE presentations: Fridays, 12:00-1:00pm Any other learning opportunity designated by the RPD or preceptor Optional activities: Depending on the clinic flow, activities and the other obligations of the resident, they may present an inservice at the end of the month to the clinic providers. The topic will be chosen based on clinic providers interest, and the length is generally 10 to 15 minutes; handouts are encouraged. The resident may present at transplant or critical care journal club (at the request of the preceptor). The resident may have the opportunity to observe a kidney, liver, or pancreas transplant surgery if interested. ROTATION PRECEPTORS: Nicole Pilch, Pharm.D., MSCR, BCPS 150 Ashley Ave; PO Box 250584 (843) 792-3702 office weimert@musc.edu James Fleming, PharmD, BCPS 150 Ashley Avenue; PO Box 250584 (843) 792-0312 office fleminj@musc.edu Holly Meadows, Pharm.D., BCPS 150 Ashley Ave; PO Box 250584 (843) 792-5861 office barrier@musc.edu

METHOD OF EVALUATION Evaluation of resident will be based on the RLS goals assigned by the Residency Program Director (RPD) in Resitrak. The preceptor and resident will review the resident s customized plan and the learning experience introduction document on the first day of rotation. Feedback will include, but not be limited to, verbal and written midpoint and end of rotation evaluations. The resident will receive formal written and verbal evaluation approximately two weeks after starting the rotation and within 3 days of completing the rotation, usually on the final day of the rotation. The final evaluation will reflect the goals and objectives identified for the rotation in Resitrak. Evaluations will incorporate feedback from the interdisciplinary team when available. In addition, the preceptor will make every attempt to provide informal feedback to the resident throughout the month. The resident is encouraged to seek feedback at any time. The resident is expected to provide verbal feedback to the preceptor regarding any areas of the rotation that could be improved to enhance the rotation, both for the month and in the future, at the midpoint and final evaluations. Interim feedback is welcome.